Press release
United States Chronic Rhinosinusitis Treatment Market 2025 | Growth Drivers, Key Players & Investment Opportunities
Chronic Rhinosinusitis Market
Global Chronic Rhinosinusitis Market reached USD 2.6 billion in 2022 and is expected to reach USD 4.5 billion by 2030, growing with a CAGR of 7.3% during the forecast period 2024-2031.
Key Development:
United States
✅ In October 2025, Lyra Therapeutics announced plans to conduct an additional clinical trial for its lead candidate, LYR-210, aimed at treating chronic rhinosinusitis without nasal polyps. The new trial design incorporates insights from previous studies and feedback from the FDA.
✅ In October 2025, Aptar Pharma and Dianosic entered into an exclusive partnership to develop the Active Resorbable Intranasal Scaffold (ARIS) technology platform. This collaboration focuses on creating an "insert and forget" intranasal drug delivery system to enhance patient adherence in treating chronic rhinitis and sinusitis.
✅ In July 2025, Sanofi reported positive Phase III study results for its pipeline drug tolebrutinib, targeting multiple sclerosis. This development underscores Sanofi's commitment to advancing treatments for chronic inflammatory conditions.
Japan
✅ In October 2025, Lyra Therapeutics announced plans to conduct an additional clinical trial for its lead candidate, LYR-210, aimed at treating chronic rhinosinusitis without nasal polyps. The new trial design incorporates insights from previous studies and feedback from the FDA.
✅ In October 2025, Aptar Pharma and Dianosic entered into an exclusive partnership to develop the Active Resorbable Intranasal Scaffold (ARIS) technology platform. This collaboration focuses on creating an "insert and forget" intranasal drug delivery system to enhance patient adherence in treating chronic rhinitis and sinusitis.
✅ In July 2025, Sanofi reported positive Phase III study results for its pipeline drug tolebrutinib, targeting multiple sclerosis. This development underscores Sanofi's commitment to advancing treatments for chronic inflammatory conditions.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/chronic-rhinosinusitis-market?sb
Recent Mergers and acquisitions:
United States
✅ In March 2025, Paratek Pharmaceuticals acquired Optinose in a deal valued at up to $330 million. This acquisition adds XHANCE®, a nasal spray for chronic rhinosinusitis, to Paratek's portfolio, expanding its presence in the ear, nose, and throat space.
✅ In March 2025, Optinose shareholders approved the merger proposal with Paratek Pharmaceuticals. Following the completion of the merger, Optinose's common stock was delisted from the Nasdaq Global Select Market, marking the finalization of the acquisition.
Key Players:
=> Lyra Therapeutics, Novartis, Medtronic plc, GlaxoSmithKline plc, AstraZeneca, Sanofi, Dr. Reddy's Laboratories Ltd, Stryker Corporation, Bayer AG, and Smith & Nephew.
Growth Forecast Projected:
The Global Chronic Rhinosinusitis Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Chronic Rhinosinusitis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=chronic-rhinosinusitis-market
Key Segments:
➥ By Disease Phenotype: Non-Eosinophilic Chronic Rhinosinusitis, Eosinophilic Chronic Rhinosinusitis, Infectious Chronic Rhinosinusitis, Allergic Fungal Rhinosinusitis, Others
➥ By Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, Others
➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
➥ By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others
Regional Analysis for Chronic Rhinosinusitis Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Chronic Rhinosinusitis producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Chronic Rhinosinusitis revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/chronic-rhinosinusitis-market?sb
FAQ
What is the current size of the Chronic Rhinosinusitis Market?
A: In 2022, the Chronic Rhinosinusitis Market was valued at USD 2.6 billion , reflecting its strong industry presence.
Q2: How large is the Chronic Rhinosinusitis Market expected to be by 2030?
A: By 2030, industry forecasts suggest the Chronic Rhinosinusitis Market will grow to around USD 4.5 billion, demonstrating significant expansion.
Q3: What is the growth rate of the Chronic Rhinosinusitis Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2024 to 2031.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Chronic Rhinosinusitis Treatment Market 2025 | Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4211802 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Online Food Delivery Market to Reach USD 291.4 Billion by 2030 | CAGR 9.1% | Asi …
Market Overview
The global online food delivery market reached USD 145.2 billion in 2022 and is projected to grow to USD 291.4 billion by 2030, registering a CAGR of 9.1% during the forecast period 2024-2031. The growth is fueled by changing consumer lifestyles, rising smartphone penetration, and the increasing popularity of contactless food delivery services. Consumers are drawn to the convenience, speed, and accuracy offered by online food delivery platforms, while…
Animal Tracking Market to Reach US$ 4.9 Billion by 2030 | CAGR 11.5% | North Ame …
Animal Tracking Market Overview
The global animal tracking market reached US$ 2.1 billion in 2022 and is projected to grow significantly, reaching US$ 4.9 billion by 2030, expanding at a CAGR of 11.5% during the forecast period (2024-2031). Animal tracking involves the development and deployment of technologies designed to monitor the location, movement, behavior, and health of animals across diverse environments.
Get a Free Sample PDF Of This Report (Get Higher Priority…
Biofuel Market to Reach US$ 252.19 Billion by 2032 | CAGR 6.4% | North America L …
Biofuel Market Overview
The global biofuel market was valued at US$ 153.88 billion in 2024 and is projected to reach US$ 252.19 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032). The market's expansion is primarily driven by increasing environmental concerns, government policies promoting renewable energy, and global efforts to reduce greenhouse gas emissions. According to the World Bioenergy Association's Global Bioenergy Statistics Report 2024, biofuels…
Lab-on-a-Chip Market to Reach US$ 14.66 Billion by 2032 | CAGR 10.12% | North Am …
Lab-on-a-Chip Market Overview
The global Lab-on-a-Chip (LoC) market reached US$ 6.78 billion in 2024 and is projected to reach US$ 14.66 billion by 2032, growing at a CAGR of 10.12% during the forecast period (2025-2032). The market growth is primarily driven by the rising demand for quick, portable, and cost-effective diagnostic solutions in medical, pharmaceutical, and research sectors. Lab-on-a-chip devices integrate multiple laboratory functions onto a single microchip, enabling real-time disease…
More Releases for Rhinosinusitis
Rhinosinusitis Market Compound Annual Growth Rate is 4.0% 2025-2034
Rhinosinusitis is an inflammation of the nasal passages and sinuses, including acute, chronic, and recurrent forms. The condition affects all age groups, leading to symptoms such as nasal congestion, facial pain, and impaired smell. The market covers pharmaceuticals, surgical interventions, diagnostics, and preventive solutions.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70755
Market Size & Growth
• 2024 Market Value: ≈ $5.8 billion globally
• 2034 Forecast: ≈ $8.2 billion globally
• Compound Annual Growth Rate (CAGR…
Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market Forecast 2025-2034
Market Overview
The Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market continues to grow due to rising sinus-related disorders, increasing environmental pollution, and advancements in diagnostic imaging and treatment approaches. In 2024, the global market value was estimated to be over USD 9.5 billion, with expectations to reach approximately USD 16.8 billion by 2034, registering a CAGR of around 6.0%.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70758
Key Market Drivers
• Increasing Prevalence of…
Chronic Rhinosinusitis (CRS) Market New Product Development & Latest Trends
Introduction
Chronic rhinosinusitis (CRS) is a persistent inflammatory condition of the paranasal sinuses lasting more than 12 weeks, characterized by nasal congestion, facial pain, loss of smell, and mucosal inflammation. Affecting millions worldwide, CRS significantly reduces quality of life and drives substantial healthcare costs due to its chronic nature and frequent relapses.
As awareness of CRS increases and treatment approaches expand beyond symptomatic relief to disease-modifying interventions, the global market for chronic…
Rhinosinusitis Market Size And Global Industry Forecast 2034
Introduction
The rhinosinusitis market focuses on the treatment and management of inflammation of the nasal cavity and paranasal sinuses, which can be acute or chronic in nature. Rhinosinusitis, often triggered by infections, allergies, or environmental factors, significantly impacts patient quality of life through nasal congestion, facial pain, headaches, and breathing difficulties.
The market is growing steadily due to rising pollution levels, increasing allergy prevalence, better diagnostic technologies, and the availability of advanced…
Chronic Rhinosinusitis with Nasal Polyps Market Worth $3.4 Billion by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Chronic Rhinosinusitis with Nasal Polyps Market- (By Treatment Type (Pharmacological Treatments (Corticosteroids, Antibiotics, Biologic Drugs, Antihistamines, Leukotriene Modifiers), Surgical Interventions, Others), By Route of Administration (Oral, Nasal, Injectable), By Distribution (Direct Sales, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialized Clinics and ENT Practices, Ambulatory Surgical Centers)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Growing Respiratory Disease Fuel Rise in Chronic Rhinosinusitis Market: Key Fact …
The Chronic Rhinosinusitis With Nasal Polyps Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chronic Rhinosinusitis With Nasal Polyps Market Size During the Forecast Period?
The chronic rhinosinusitis with nasal polyps market size has grown strongly in recent years. It will increase…
